Alexander S. Semikhin
Moscow, MOW 123098, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Adenoviral Vectors Expressing Optimized preM/E Genes of WNV Deliver Long-Term Protection Against Lethal West Nile Virus Challenge.
Journal: Vaccines
Published: October 27, 2025
Safety and immunogenicity of GamEvac-Combi, a heterologous rVSV- and rAd5-vectored Ebola vaccine: a randomized controlled multicenter clinical trial in the Republic of Guinea and Russia.
Journal: Frontiers in immunology
Published: August 27, 2024
Immunogenicity and Protectivity of Sputnik V Vaccine in hACE2-Transgenic Mice against Homologous and Heterologous SARS-CoV-2 Lineages Including Far-Distanced Omicron BA.5.
Journal: Vaccines
Published: August 21, 2024
Nonimmunogenic staphylokinase in the treatment of acute ischemic stroke (FRIDA trial results)
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: July 29, 2022
An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine "Sputnik Light" for prevention of coronavirus infection in healthy adults.
Journal: The Lancet regional health. Europe
Published: November 08, 2021
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia.
Journal: Lancet (London, England)
Published: December 31, 2020
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia.
Journal: Lancet (London, England)
Published: August 17, 2020
Production of mycobacterial antigenes merged with cellulose binding protein domain in order to produce subunit vaccines against tuberculosis
Journal: Molekuliarnaia genetika, mikrobiologiia i virusologiia
Published: June 19, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026